White Paper | Mitigating Risks in Pharmaceutical Batch Release

Enabling contingency sourcing for analytical supplies

To ensure business continuity in relation to Quality Control programs and release of pharmaceutical products, an analytical supply chain risk mitigation program supporting sourcing of reagents, columns and other analytical consumables can help the agility of your organisation to respond to supply based challenges, for example, such as those associated with COVID-19 or Brexit.

In this white paper, our expert Corinne Roberts, describes what steps an analytical supply chain risk mitigation program might include, the considerations for success when outsourcing these to a contract laboratory services partner and the advantages that stem from these programs.

 

Please complete the form below to access the white paper.